Liu, Yang http://orcid.org/0000-0001-9971-8191
Gao, Yamin
Liu, Jianxiong
Tan, Yaoju
Liu, Zhiyong
Chhotaray, Chiranjibi
Jiang, Huofeng
Lu, Zhili
Chiwala, Gift
Wang, Shuai
Makafe, Gaelle http://orcid.org/0000-0002-7577-4225
Islam, Md Mahmudul
Hameed, H. M. Adnan
Cai, Xingshan
Wang, Changwei
Li, Xinjie
Tan, Shouyong
Zhang, Tianyu http://orcid.org/0000-0001-5647-6014
Article History
Received: 11 November 2018
Accepted: 19 December 2018
First Online: 31 January 2019
Competing interests
: All authors declare competing interests: TB47 was synthesized in a batch and supplied by Guangzhou Eggbio Co. Ltd, which has been developing TB47 as a therapeutic agent against tuberculosis and other potential diseases and had no role in study design, data collection and analysis, decision to publish the manuscript. Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS) has filed a Chinese application (filing # 201810106538.9) and a PCT application (filing # CN2018/077992), entitled ‘New use of a set of pyridine compounds’, listing T.Z. and Y.L. as inventors.